AAAAAA

   
Results: 1-25 | 26-43
Results: 1-25/43
RECOGNITION OF MELANOMA-DERIVED ANTIGENS BY CTL - POSSIBLE MECHANISMSINVOLVED IN DOWN-REGULATING ANTITUMOR T-CELL REACTIVITY
Authors: RIVOLTINI L LOFTUS DJ SQUARCINA P CASTELLI C RINI F ARIENTI F BELLI F MARINCOLA FM GEISLER C BORSATTI A APPELLA E PARMIANI G
Citation: L. Rivoltini et al., RECOGNITION OF MELANOMA-DERIVED ANTIGENS BY CTL - POSSIBLE MECHANISMSINVOLVED IN DOWN-REGULATING ANTITUMOR T-CELL REACTIVITY, Critical reviews in immunology, 18(1-2), 1998, pp. 55-63
S100 PROTEIN SERUM LEVELS IN CUTANEOUS MALIGNANT-MELANOMA
Authors: SEREGNI E MASSARON S MARTINETTI A ILLENI MT ROVINI D BELLI F AGRESTI R GRECO M CASCINELLI N BOMBARDIERI E
Citation: E. Seregni et al., S100 PROTEIN SERUM LEVELS IN CUTANEOUS MALIGNANT-MELANOMA, Oncology Reports, 5(3), 1998, pp. 601-604
COMBINED EFFECTS OF INTERFERON-ALPHA-2A AND 13-CIS-RETINOIC ACID ON HUMAN-MELANOMA CELL-GROWTH AND STAT PROTEIN EXPRESSION
Authors: BEARZATTO A ORLANDI L SILVESTRINI R BELLI F CASCINELLI N ZAFFARONI N
Citation: A. Bearzatto et al., COMBINED EFFECTS OF INTERFERON-ALPHA-2A AND 13-CIS-RETINOIC ACID ON HUMAN-MELANOMA CELL-GROWTH AND STAT PROTEIN EXPRESSION, Melanoma research, 8(1), 1998, pp. 31-38
EVALUATION OF CLINICAL EFFICACY AND TOLERABILITY OF INTRAVENOUS HIGH-DOSE THYMOPENTIN IN ADVANCED MELANOMA PATIENTS
Authors: CASCINELLI N BELLI F MASCHERONI L LENISA L CLEMENTE C
Citation: N. Cascinelli et al., EVALUATION OF CLINICAL EFFICACY AND TOLERABILITY OF INTRAVENOUS HIGH-DOSE THYMOPENTIN IN ADVANCED MELANOMA PATIENTS, Melanoma research, 8(1), 1998, pp. 83-89
SENTINEL NODE BIOPSY AND SELECTIVE DISSECTION FOR MELANOMA NODAL METASTASES
Authors: BELLI F LENISA L CLEMENTE C TRAGNI G MASCHERONI L GALLINO G CASCINELLI N
Citation: F. Belli et al., SENTINEL NODE BIOPSY AND SELECTIVE DISSECTION FOR MELANOMA NODAL METASTASES, Tumori, 84(1), 1998, pp. 24-28
EVALUATION ON SERUM 2'-5' OLIGOADENYLATE SYNTHETASE (2'-5' OLIGOAS) AND BETA-2-MICROGLOBULIN (B2M) IN PATIENTS WITH NODAL METASTASES FROM CUTANEOUS MALIGNANT-MELANOMA TREATED WITH RIFN-ALPHA-2A
Authors: MARTINETTI A SEREGNI E BELLI F MAZZOCCHI A AGRESTI R CASCINELLI N GRECO M BOMBARDIERI E
Citation: A. Martinetti et al., EVALUATION ON SERUM 2'-5' OLIGOADENYLATE SYNTHETASE (2'-5' OLIGOAS) AND BETA-2-MICROGLOBULIN (B2M) IN PATIENTS WITH NODAL METASTASES FROM CUTANEOUS MALIGNANT-MELANOMA TREATED WITH RIFN-ALPHA-2A, Anticancer research, 18(3B), 1998, pp. 2027-2030
DISSECTION OF REGIONAL LYMPH-NODES IN CUTANEOUS MELANOMA - REPLY
Authors: CASCINELLI N MORABITO A SANTINAMI M MACKIE RM BELLI F
Citation: N. Cascinelli et al., DISSECTION OF REGIONAL LYMPH-NODES IN CUTANEOUS MELANOMA - REPLY, Lancet, 351(9119), 1998, pp. 1885-1885
IMMEDIATE OR DELAYED DISSECTION OF REGIONAL NODES IN PATIENTS WITH MELANOMA OF THE TRUNK - A RANDOMIZED TRIAL
Authors: CASCINELLI N MORABITO A SANTINAMI M MACKIE RM BELLI F
Citation: N. Cascinelli et al., IMMEDIATE OR DELAYED DISSECTION OF REGIONAL NODES IN PATIENTS WITH MELANOMA OF THE TRUNK - A RANDOMIZED TRIAL, Lancet, 351(9105), 1998, pp. 793-796
HUMAN MELANOMA-REACTIVE CD4(-INDUCED APOPTOSIS AND USE FAS() AND CD8(+) CTL CLONES RESIST FAS LIGAND)FAS LIGAND-INDEPENDENT MECHANISMS FOR TUMOR KILLING/
Authors: RIVOLTINI L RADRIZZANI M ACCORNERO P SQUARCINA P CHIODONI C MAZZOCCHI A CASTELLI C TARSINI P VIGGIANO V BELLI F COLOMBO MP PARMIANI G
Citation: L. Rivoltini et al., HUMAN MELANOMA-REACTIVE CD4(-INDUCED APOPTOSIS AND USE FAS() AND CD8(+) CTL CLONES RESIST FAS LIGAND)FAS LIGAND-INDEPENDENT MECHANISMS FOR TUMOR KILLING/, The Journal of immunology (1950), 161(3), 1998, pp. 1220-1230
IMMUNOGENICITY OF THE ALLAVGATK (GP100(17-25)) PEPTIDE IN HLA-A3.1 MELANOMA PATIENTS
Authors: CASTELLI C MAZZOCCHI A RINI F TARSINI P RIVOLTINI L MAIO M GALLINO G BELLI F PARMIANI G
Citation: C. Castelli et al., IMMUNOGENICITY OF THE ALLAVGATK (GP100(17-25)) PEPTIDE IN HLA-A3.1 MELANOMA PATIENTS, European Journal of Immunology, 28(4), 1998, pp. 1143-1154
NEUROTOXICITY OF INTERFERON-ALPHA IN MELANOMA THERAPY - RESULTS FROM A RANDOMIZED CONTROLLED TRIAL
Authors: CARACENI A GANGERI L MARTINI C BELLI F BRUNELLI C BALDINI M MASCHERONI L LENISA L CASCINELLI N
Citation: A. Caraceni et al., NEUROTOXICITY OF INTERFERON-ALPHA IN MELANOMA THERAPY - RESULTS FROM A RANDOMIZED CONTROLLED TRIAL, Cancer, 83(3), 1998, pp. 482-489
RESULTS OF ENDOSCOPIC ULTRASONOGRAPHY IN PREOPERATIVE DETECTION OF NODAL METASTASES FROM RECTAL-CANCER
Authors: SPINELLI P SCHIAVO M ANDREOLA S LEO E BELLI F GALLINO G DIFELICE G
Citation: P. Spinelli et al., RESULTS OF ENDOSCOPIC ULTRASONOGRAPHY IN PREOPERATIVE DETECTION OF NODAL METASTASES FROM RECTAL-CANCER, British Journal of Surgery, 85, 1998, pp. 15-15
ACTIVE IMMUNIZATION OF MELANOMA PATIENTS WITH IL-2-TRANSDUCED OR IL-4-TRANSDUCED ALLOGENEIC MELANOMA-CELLS
Authors: ARIENTI F BELLI F MAZZOCCHI A GALLINO F NAPOLITANO F MELANI C COLOMBO MP RIVOLTINI L MAIO M PARMIANI G
Citation: F. Arienti et al., ACTIVE IMMUNIZATION OF MELANOMA PATIENTS WITH IL-2-TRANSDUCED OR IL-4-TRANSDUCED ALLOGENEIC MELANOMA-CELLS, European journal of cancer, 33, 1997, pp. 1303-1303
T-CELL RECOGNITION OF MELANOMA-DERIVED ANTIGENS - IMPLICATION FOR PEPTIDE-BASED IMMUNOTHERAPY
Authors: RIVOLTINI L MAZZOCCHI A SQUARCINA P ARIENTI F BELLI F CASTELLI C MARINCOLA FM LOFTUS DJ PARMIANI G
Citation: L. Rivoltini et al., T-CELL RECOGNITION OF MELANOMA-DERIVED ANTIGENS - IMPLICATION FOR PEPTIDE-BASED IMMUNOTHERAPY, European journal of cancer, 33, 1997, pp. 1313-1313
ACTIVE IMMUNIZATION OF METASTATIC MELANOMA PATIENTS WITH IL-2 OR IL-4GENE TRANSFERRED, ALLOGENEIC MELANOMA-CELLS
Authors: BELLI F MASCHERONI L GALLINO G LENISA L ARIENTI F PARMIANI G CASCINELLI N
Citation: F. Belli et al., ACTIVE IMMUNIZATION OF METASTATIC MELANOMA PATIENTS WITH IL-2 OR IL-4GENE TRANSFERRED, ALLOGENEIC MELANOMA-CELLS, Cancer gene therapy, 4(5), 1997, pp. 334-334
ACTIVE IMMUNIZATION OF METASTATIC MELANOMA PATIENTS WITH INTERLEUKIN-2-TRANSDUCED ALLOGENEIC MELANOMA-CELLS - EVALUATION OF EFFICACY AND TOLERABILITY (VOL 44, PG 197, 1997)
Authors: BELLI F ARIENTI F SULESUSO J CLEMENTE C MASCHERONI L CATTELAN A SANTANTONIO C GALLINO GF MELANI C RAO S COLOMBO MP MAIO M CASCINELLI N PARMIANI G
Citation: F. Belli et al., ACTIVE IMMUNIZATION OF METASTATIC MELANOMA PATIENTS WITH INTERLEUKIN-2-TRANSDUCED ALLOGENEIC MELANOMA-CELLS - EVALUATION OF EFFICACY AND TOLERABILITY (VOL 44, PG 197, 1997), Cancer immunology and immunotherapy, 45(2), 1997, pp. 119-119
ACTIVE IMMUNIZATION OF METASTATIC MELANOMA PATIENTS WITH INTERLEUKIN-2-TRANSDUCED ALLOGENEIC MELANOMA-CELLS - EVALUATION OF EFFICACY AND TOLERABILITY
Authors: BELLI F ARIENTI F SULESUSO J CLEMENTE C MASCHERONI L CATTELAN A SANANTONIO C GALLINO GF MELANI C RAO S COLOMBO MP MAIO M CASCINELLI N PARMIANI G
Citation: F. Belli et al., ACTIVE IMMUNIZATION OF METASTATIC MELANOMA PATIENTS WITH INTERLEUKIN-2-TRANSDUCED ALLOGENEIC MELANOMA-CELLS - EVALUATION OF EFFICACY AND TOLERABILITY, Cancer immunology and immunotherapy, 44(4), 1997, pp. 197-203
DISTAL INTRAMURAL SPREAD IN ADENOCARCINOMA OF THE LOWER 1 3 OF THE RECTUM TREATED WITH TOTAL RECTAL RESECTION AND COLOANAL ANASTOMOSIS/
Authors: ANDREOLA S LEO E BELLI F LAVARINO C BUFALINO R TOMASIC G BALDINI MT VALVO F NAVARRIA P LOMBARDI F
Citation: S. Andreola et al., DISTAL INTRAMURAL SPREAD IN ADENOCARCINOMA OF THE LOWER 1 3 OF THE RECTUM TREATED WITH TOTAL RECTAL RESECTION AND COLOANAL ANASTOMOSIS/, Diseases of the colon & rectum, 40(1), 1997, pp. 25-29
AUTOLOGOUS DENDRITIC CELLS DERIVED FROM CD34(-PRESENTING CELLS IN THEINDUCTION OF MELAN-A() PROGENITORS AND FROM MONOCYTES ARE NOT FUNCTIONALLY EQUIVALENT ANTIGEN)MART-1(27-35)-SPECIFIC CTLS FROM PERIPHERAL-BLOOD LYMPHOCYTES OF MELANOMA PATIENTS WITH LOW-FREQUENCY OF CTL PRECURSORS/
Authors: MORTARINI R ANICHINI A DINICOLA M SIENA S BREGNI M BELLI F MOLLA A GIANNI AM PARMIANI G
Citation: R. Mortarini et al., AUTOLOGOUS DENDRITIC CELLS DERIVED FROM CD34(-PRESENTING CELLS IN THEINDUCTION OF MELAN-A() PROGENITORS AND FROM MONOCYTES ARE NOT FUNCTIONALLY EQUIVALENT ANTIGEN)MART-1(27-35)-SPECIFIC CTLS FROM PERIPHERAL-BLOOD LYMPHOCYTES OF MELANOMA PATIENTS WITH LOW-FREQUENCY OF CTL PRECURSORS/, Cancer research, 57(24), 1997, pp. 5534-5541
PHARMACOKINETICS AND EFFECTS ON PLASMA RETINOL CONCENTRATIONS OF 13-CIS-RETINOIC ACID IN MELANOMA PATIENTS
Authors: FORMELLI F CAVADINI E MASCHERONI L BELLI F CASCINELLI N
Citation: F. Formelli et al., PHARMACOKINETICS AND EFFECTS ON PLASMA RETINOL CONCENTRATIONS OF 13-CIS-RETINOIC ACID IN MELANOMA PATIENTS, British Journal of Cancer, 76(12), 1997, pp. 1655-1660
TOTAL RECTAL RESECTION, MESORECTUM EXCISION, AND COLOENDOANAL ANASTOMOSIS - A THERAPEUTIC OPTION FOR THE TREATMENT OF LOW RECTAL-CANCER
Authors: LEO E BELLI F ANDREOLA S BALDINI MT GALLINO GF GIOVANAZZI R MASCHERONI L PATUZZO R VITELLARO M LAVARINO C BUFALINO R
Citation: E. Leo et al., TOTAL RECTAL RESECTION, MESORECTUM EXCISION, AND COLOENDOANAL ANASTOMOSIS - A THERAPEUTIC OPTION FOR THE TREATMENT OF LOW RECTAL-CANCER, Annals of surgical oncology, 3(4), 1996, pp. 336-343
DIFFERENCES IN FREQUENCY-DISTRIBUTION OF HLA-A2 SUBTYPES BETWEEN NORTH-AMERICAN AND ITALIAN WHITE MELANOMA PATIENTS - RELEVANCE FOR EPITOPE-SPECIFIC VACCINATION PROTOCOLS
Authors: PLAYER MA BARRACCHINI KC SIMONIS TB RIVOLTINI L ARIENTI F CASTELLI C MAZZOCCHI A BELLI F PARMIANI G MARINCOLA FM
Citation: Ma. Player et al., DIFFERENCES IN FREQUENCY-DISTRIBUTION OF HLA-A2 SUBTYPES BETWEEN NORTH-AMERICAN AND ITALIAN WHITE MELANOMA PATIENTS - RELEVANCE FOR EPITOPE-SPECIFIC VACCINATION PROTOCOLS, Journal of immunotherapy with emphasis on tumor immunology, 19(5), 1996, pp. 357-363
LIMITED ANTITUMOR T-CELL RESPONSE IN MELANOMA PATIENTS VACCINATED WITH INTERLEUKIN-2 GENE-TRANSDUCED ALLOGENEIC MELANOMA-CELLS
Authors: ARIENTI F SULESUSO J BELLI F MASCHERONI L RIVOLTINI L MELANI C MAIO M CASCINELLI N COLOMBO MP PARMIANI G
Citation: F. Arienti et al., LIMITED ANTITUMOR T-CELL RESPONSE IN MELANOMA PATIENTS VACCINATED WITH INTERLEUKIN-2 GENE-TRANSDUCED ALLOGENEIC MELANOMA-CELLS, Human gene therapy, 7(16), 1996, pp. 1955-1963
BIOLOGICAL-ACTIVITY AND CLINICAL EFFICACY OF INTRAVENOUS HIGH-DOSE THYMOPENTIN IN METASTATIC MELANOMA PATIENTS
Authors: CLEMENTE C BELLI F MASCHERONI L BUFALINO R RAO S BALDINI MT MIHM MC CASCINELLI N
Citation: C. Clemente et al., BIOLOGICAL-ACTIVITY AND CLINICAL EFFICACY OF INTRAVENOUS HIGH-DOSE THYMOPENTIN IN METASTATIC MELANOMA PATIENTS, Melanoma research, 6(1), 1996, pp. 63-69
HLA-A3-RESTRICTED CTL DEFINED ANTIGENS SHARED AMONG HUMAN MELANOMAS BUT NOT MELANOCYTES
Authors: MAZZOCCHI A CASTELLI C TRAVERSARI C STORKUS WJ RIVOLTINI L BELLI F MASCHERONI L VEGETTI C ANICHINI A PARMIANI G
Citation: A. Mazzocchi et al., HLA-A3-RESTRICTED CTL DEFINED ANTIGENS SHARED AMONG HUMAN MELANOMAS BUT NOT MELANOCYTES, The FASEB journal, 10(6), 1996, pp. 2520-2520
Risultati: 1-25 | 26-43